E Point Perfect
Law \ Legal

Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Invests in iXCells Biotechnologies

Great Point Partners (GPP) has completed a growth investment in iXCells Biotechnologies, according to a news release.

iXCells, based in San Diego, is a provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide. Founded in 2014, the company focuses on primary and induced pluripotent stem cell-derived cellular models.

GPP, based in Greenwich, Conn., is a private investment firm focused on the healthcare industry. Founded in 2003, the firm targets investments in biopharmaceutical supply chain services and products; healthcare services; healthcare information technology-enabled services; and medical devices and diagnostics in businesses operating in the United States, Canada and Western Europe. GPP pursues companies generating between $10 million and $100 million of revenue and $2 million to $12 million of EBITDA, with equity investments ranging from $7 million to $50 million.

Terms of the investment were not disclosed.

Source link

Related posts

Deadly Listeria outbreak traced to deli meat and cheese; CDC says some should avoid all delis

DHS Announces That Employers Should Continue to Use the Current I-9 Form After the Oct 31, 2022, Expiration

Populus Financial Group moves for dismissal of CFPB lawsuit and stay pending Fifth Circuit decision

Electronic Transactions Association (ETA) Payments Compliance Conference

How to Get Paid on Georgia Public Projects

IOSCO final report ‘Investor behaviour and investor education in times of turmoil: Recommended framework for regulators based on lessons learned from the COVID- 19 pandemic’